When to treat CLL

Ultima Vez Modificado: 11 de mayo del 2003

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Fludarabine, Alemtuzumab Combo Ups Survival in CLL

Oct 12, 2011

But combination therapy is associated with more adverse events than fludarabine monotherapy

FDA Expands Imbruvica Approval to Include CLL

Feb 14, 2014

Approval of Imbruvica (ibrutinib) expanded to include people with chronic lymphocytic leukemia

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

Sep 3, 2015

T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells